4.8 Article

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Urology & Nephrology

Warfarin Dosing in Patients With Impaired Kidney Function

Nita A. Limdi et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2010)

Article Cardiac & Cardiovascular Systems

Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

Michael D. Ezekowitz et al.

AMERICAN HEART JOURNAL (2009)

Review Anesthesiology

The Role of Tissue Factor and Factor VIIa in Hemostasis

Nigel Mackman

ANESTHESIA AND ANALGESIA (2009)

Review Pharmacology & Pharmacy

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

Bengt I. Eriksson et al.

CLINICAL PHARMACOKINETICS (2009)

Article Medicine, General & Internal

Dabigatran versus Warfarin in Patients with Atrial Fibrillation.

Stuart J. Connolly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Clinical Neurology

Predictors of outcome in warfarin-related intracerebral hemorrhage

Alexander Y. Zubkov et al.

ARCHIVES OF NEUROLOGY (2008)

Article Hematology

Combined antiplatelet and anticoagulant therapy: clinical benefits and risks

J. W. Eikelboom et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

Review Cardiac & Cardiovascular Systems

Tissue factor in cardiovascular diseases -: Molecular mechanisms and clinical implications

J Steffel et al.

CIRCULATION (2006)

Review Gastroenterology & Hepatology

Lower GI bleeding: Epidemiology and diagnosis

LL Strate

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2005)